Nitrous Oxide for Analgesia During Nasogastric Tube Placement in Young Children (SONGER)
Primary Purpose
Mild to Moderate Dehydration
Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Nitrous Oxide
Sponsored by
About this trial
This is an interventional treatment trial for Mild to Moderate Dehydration focused on measuring Pain, nasogastric tube, children, infants, analgesia, nitrous oxide
Eligibility Criteria
Inclusion Criteria:
- Child from 3 months to 3 years old.
- Admission to the Pediatric Emergency Department
- Medical prescription for the insertion of a nasogastric tube.
- Child with gastroenteritis and / or bronchiolitis and / or food intolerance with mild to moderate dehydration
- Parental presence and parental consent
Exclusion Criteria:
- Vital emergency.
- Refusal of parents.
- Refusal of parents to be filmed
- Child already included in the study or in course of participation in another study.
- Tube placement performed by a medical student or nursing student.
- Patient requiring 100% oxygen ventilation.
- No social security.
- Child with a mental handicap or known retardation
- History of child intolerance to Nitrous oxide ( excessive sedation or respiratory depression during previous use)
- Child with head trauma in the previous 3 days
Premature discontinuation of study participation :
- Parents' request to stop participating in the study.
- Insertion of the nasogastric tube is not possible
Sites / Locations
- Trousseau Hospital, Pediatric emergency departmentRecruiting
- Poissy Hospital, Pediatric emergency departmentRecruiting
- Ambroise Paré hospital, Pediatric emergency department
- Louis Mourier Hospital, Pediatric emergency departmentRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
Nitrous oxide
Standard care
Arm Description
Inhalation of a 50%/50% mixture of nitrous oxide and oxygen. Reassurance of the child during procedure
Infants will be reassured as currently performed in routine clinical practice
Outcomes
Primary Outcome Measures
Pain during nasogastric tube insertion
Pain will be assessed during nasogastric tube insertion with the Face Legs Activity Cry Consolability (FLACC) scale composed of five scale (face, legs, activities, shouting, consolability). Each ranks from 0 to 2 : 0 is no pain, 1 is average pain, 2 is a strong pain The outcome measure is the sum of these five subscales: from 0 (better outcome) to 10 (worse outcome).
Secondary Outcome Measures
Parent's anxiety 10 scale.
The parent evaluates himself his anxiety. It's a simple scale graduate one by one, from 0 (better outcome) to 10 (worse outcome). Based on their subjective interpretation of their own anxiety
Child's constraint needed during the procedure
Scale for grading the level of constraint during the procedure It is composed to three subscales from 0 to 3 (head, arms, legs). 0 is no contention, 1 is soft hold, 2 is firm support, 3 is very firm hold And one subscale from 0 to 1 (trunk). 0 is no contention, 1 is necessary maintenance.
The outcome measure is the sum of these four subscales: from 0 (better outcome, that is to say no contention) to 10 (strongest contention).
The potential side effects of the mixture 50%/50% nitrous oxide/oxygen for a brief inhalation are : Euphoria, dreaming, hallucinations, sedation, headaches, nausea, and vomiting.
The rate of side effects will be described
Full Information
NCT ID
NCT04008628
First Posted
July 2, 2019
Last Updated
February 2, 2023
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
URC-CIC Paris Descartes Necker Cochin
1. Study Identification
Unique Protocol Identification Number
NCT04008628
Brief Title
Nitrous Oxide for Analgesia During Nasogastric Tube Placement in Young Children
Acronym
SONGER
Official Title
Analgesia by 50%/50% Nitrous Oxide/Oxygen Mixture for Nasogastric Catheterization in Children Aged 3 Months to 3 Years
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 10, 2021 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
URC-CIC Paris Descartes Necker Cochin
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
Since nitrous oxide/oxygen mixture is effective to reduce pain and anxiety induced by various painful procedures in children, the investigators hypothesized that its inhalation would reduce pain during nasogastric tube placement in young children.
The purpose of this study is to evaluate the analgesic efficacy of 50%/50% nitrous/oxide mixture in reducing pain induced by nasogastric tube insertion in children aged 3 months to 3 years in the pediatric emergency department.
Detailed Description
In the context of mild to moderate dehydration in young children, enteral rehydration is the treatment of choice because it is more physiological than parenteral rehydration which has more serious side effects. Thus, nasogastric tube placement has become a more common procedure in the pediatric emergency care setting. Although, it is widely accepted that this procedure is invasive and painful, to date, no analgesic approach has been shown to be effective for children aged 3 months to 3 years. Currently, standard care is the placement of nasogastric tube without any analgesic intervention.
Inhalation of nitrous oxide mixed with oxygen (50/50) has been shown to be effective to reduce pain and anxiety induced by invasive procedures in children, adolescents and adults. Its use is very safe and it is associated with only minor and transient side effects such as nausea, vomiting or dizziness in les than 10% of patients. Its use is very common in many countries such as France, United Kingdom, The Netherlands or Australia. The investigators hypothesized that its inhalation would reduce pain during nasogastric tube placement in young children.
The purpose of this study is to evaluate the analgesic efficacy of 50%/50% nitrous/oxide mixture in reducing pain induced by nasogastric tube insertion in children aged 3 months to 3 years in the pediatric emergency department.
A randomized controlled trial will be performed in two pediatric emergency departments to assess the efficacy of 50/50 nitrous oxide/oxygen during nasogastric tube insertion. The control group will receive standard care.
Primary outcome: Pain assessed with the FLACC scale during tube insertion
The investigators believe that this randomized study comparing nitrous oxide inhalation against current practice (no analgesic means) will highlight the intensity of pain caused by nasogastric tube placement and will assess the effectiveness of nitrous oxide inhalation to reduce pain and anxiety induced by the procedure
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mild to Moderate Dehydration
Keywords
Pain, nasogastric tube, children, infants, analgesia, nitrous oxide
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
The primary outcome will be assessed on video recordings of the procedures which will be prepared so that assessors will not know to which group the children assigned. This correspond to a blind assessment of the primary outcome.
Allocation
Randomized
Enrollment
160 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Nitrous oxide
Arm Type
Active Comparator
Arm Description
Inhalation of a 50%/50% mixture of nitrous oxide and oxygen. Reassurance of the child during procedure
Arm Title
Standard care
Arm Type
No Intervention
Arm Description
Infants will be reassured as currently performed in routine clinical practice
Intervention Type
Drug
Intervention Name(s)
Nitrous Oxide
Intervention Description
Inhalation of a 50%/50% nitrous oxide/oxygen mixture (Kalinox®)
Primary Outcome Measure Information:
Title
Pain during nasogastric tube insertion
Description
Pain will be assessed during nasogastric tube insertion with the Face Legs Activity Cry Consolability (FLACC) scale composed of five scale (face, legs, activities, shouting, consolability). Each ranks from 0 to 2 : 0 is no pain, 1 is average pain, 2 is a strong pain The outcome measure is the sum of these five subscales: from 0 (better outcome) to 10 (worse outcome).
Time Frame
From the beginning of the procedures until 2 minutes after final positioning of the tube
Secondary Outcome Measure Information:
Title
Parent's anxiety 10 scale.
Description
The parent evaluates himself his anxiety. It's a simple scale graduate one by one, from 0 (better outcome) to 10 (worse outcome). Based on their subjective interpretation of their own anxiety
Time Frame
During procedure
Title
Child's constraint needed during the procedure
Description
Scale for grading the level of constraint during the procedure It is composed to three subscales from 0 to 3 (head, arms, legs). 0 is no contention, 1 is soft hold, 2 is firm support, 3 is very firm hold And one subscale from 0 to 1 (trunk). 0 is no contention, 1 is necessary maintenance.
The outcome measure is the sum of these four subscales: from 0 (better outcome, that is to say no contention) to 10 (strongest contention).
Time Frame
During procedure
Title
The potential side effects of the mixture 50%/50% nitrous oxide/oxygen for a brief inhalation are : Euphoria, dreaming, hallucinations, sedation, headaches, nausea, and vomiting.
Description
The rate of side effects will be described
Time Frame
from the start of inhalation to nearly 5 to 10 minutes after the end of inhalation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
3 Months
Maximum Age & Unit of Time
3 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Child from 3 months to 3 years old.
Admission to the Pediatric Emergency Department
Medical prescription for the insertion of a nasogastric tube.
Child with gastroenteritis and / or bronchiolitis and / or food intolerance with mild to moderate dehydration
Parental presence and parental consent
Exclusion Criteria:
Vital emergency.
Refusal of parents.
Refusal of parents to be filmed
Child already included in the study or in course of participation in another study.
Tube placement performed by a medical student or nursing student.
Patient requiring 100% oxygen ventilation.
No social security.
Child with a mental handicap or known retardation
History of child intolerance to Nitrous oxide ( excessive sedation or respiratory depression during previous use)
Child with head trauma in the previous 3 days
Premature discontinuation of study participation :
Parents' request to stop participating in the study.
Insertion of the nasogastric tube is not possible
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ricardo CARBAJAL, Md, Phd
Phone
+33144736188
Email
ricardo.carbajal@aphp.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Guillaume Masson, Msc
Phone
+331 58 41 34 78
Email
guillaume.masson@aphp.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marie Beauchet-Filleau, nurse
Organizational Affiliation
Trousseau Hospital, pediatric emergency
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ricardo Carbajal, Professor
Organizational Affiliation
Trousseau Hospital, pediatric emergency
Official's Role
Study Director
Facility Information:
Facility Name
Trousseau Hospital, Pediatric emergency department
City
Paris
State/Province
Ile De France
ZIP/Postal Code
75012
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lucie Touchard, nurse
Email
luci.touchard@aphp.fr
First Name & Middle Initial & Last Name & Degree
Ricardo CARBAJAL, MD, PhD
Facility Name
Poissy Hospital, Pediatric emergency department
City
Poissy
State/Province
Ile De France
ZIP/Postal Code
78300
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Isabelle BADIER, MD
Phone
+33 1 39 27 55 91
Email
badier.isa@gmail.com
First Name & Middle Initial & Last Name & Degree
Isabelle BADIER, MD
Facility Name
Ambroise Paré hospital, Pediatric emergency department
City
Boulogne-Billancourt
ZIP/Postal Code
92100
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Valérie SOUSSAN-BANINI, MD
Email
valerie.soussan-banini@aphp.fr
First Name & Middle Initial & Last Name & Degree
Valérie SOUSSAN-BANINI, MD
Facility Name
Louis Mourier Hospital, Pediatric emergency department
City
Colombes
ZIP/Postal Code
92700
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Romain BASMACI, MD
Email
romain.basmaci@aphp.fr
First Name & Middle Initial & Last Name & Degree
Romain BASMACI, MD
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Nitrous Oxide for Analgesia During Nasogastric Tube Placement in Young Children
We'll reach out to this number within 24 hrs